Gene expression profile of human Down syndrome leukocytes

Croatian Medical Journal

Volumn 46, Issue 4, 2005, Pages 647-656

  Malagó Jr , Wilson ^a   Sommer, César A ^a   Del Cistia Andrade, Camillo ^a   Soares Costa, Andrea ^a   Possik, Patrícia Abrao ^a   Cassago, Alexandre ^a   Santejo Silveira, Henrique C ^a   Henrique Silva, Flávio ^a  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GROWTH FACTOR; INTERLEUKIN 8; RIBOSOME PROTEIN; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CASE REPORT; CLUSTER ANALYSIS; DNA LIBRARY; DOWN SYNDROME; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; LEUKOCYTE; MALE; MOLECULAR MECHANICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION;

ADULT; BASE SEQUENCE; DNA PRIMERS; DOWN SYNDROME; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 24344463124     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Epstein CJ. Down syndrome (trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: Mc Graw-Hill; 1995. p. 749-794.
2. Antonarakis SE. 10 years of Genomics, chromosome 21, and Down syndrome. Genomics. 1998;51:1-16.
3. Rahmani Z, Blouin JL, Creau-Goldberg N, Watkins PC, Mattel JF, Poissonnier M, et al. Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc Natl Acad Sci USA. 1989;86: 5958-62.
4. McCormick MK, Schinzel A, Petersen MB, Stetten G, Driscoll DJ, Cantu ES, et al. Molecular genetic approach to the characterization of the "Down syndrome region" of chromosome 21. Genomics. 1989;5:325-31.
5. Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet 1993;1:114-24.
6. Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, Gerwehr S, et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA. 1994;91:4997-5001.
7. Olson LE, Richtsmeier JT, Leszl J, Reeves RH. A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science. 2004;306:687-90.
8. Chrast R, Scott HS, Papasavvas MP, Rossier C, Antonarakis ES, Barras C, et al. The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res. 2000;10:2006-21.
9. Van Keuren ML, Goldman D, Merril CR. Protein variations associated with Down's syndrome, chromosome 21, and Alzheimer's disease. Ann N Y Acad Sci. 1982; 396:55-67.
10. Whatley SA, Hall C, Davison AN, Lim L. Alterations in the relative amounts of specific mRNA species in the developing human brain in Down's syndrome. Biochem. J. 1984;220:179-87.
11. Mao R, Zielke CL, Zielke HR, Pevsner J. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics. 2003;81:457-67.
12. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science. 1995;270: 484-7.
13. Kozian DH, Kirschbaum BJ. Comparative gene-expression analysis. Trends Biotechnol. 1999;17:73-8.
14. Velculescu VE, Zhang L, Zhou W, Vogelstein J, Basrai MA, Bassett DE Jr, et al. Characterization of the yeast transcriptome. Cell. 1997;88:243-51.
15. Margulies EH, Innis JW. eSAGE: managing and analysing data generated with serial analysis of gene expression (SAGE). Bioinformatics. 2000;16:650-1.
16. Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001.
17. Pritchard MA, Kola I. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome. J Neural Transm Suppl. 1999;57:293-303.
18. Velculescu VE, Vogelstein B, Kinzler KW. Analysing uncharted transcriptomes with SAGE. Trends Genet. 2000;16:423-5.
19. Silva AP, De Souza JE, Galante PA, Riggins GJ, De Souza SJ, Camargo AA. The impact of SNPs on the interpretation of SAGE and MPSS experimental data. Nucleic Acids Res. 2004;32:6104-10.
20. FitzPatrick DR, Ramsay J, McGill NI, Shade M, Carothers AD, Hastie ND. Transcriptome analysis of human autosomal trisomy. Hum Mol Genet. 2002;11: 3249-56.
21. Dauphinot L, Lyle R, Rivals I, Dang MT, Moldrich RX, Golfier G, et al. The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome. Hum Mol Genet. 2005;14:373-84.
22. Giannone S, Strippoli P, Vitale L, Casadei R, Canaider S, Lenzi L, et al. Gene expression profile analysis in human T lymphocytes from patients with down syndrome. Ann Hum Genet. 2004;68:546-54.
23. Hashimoto S, Nagai S, Sese J, Suzuki T, Obata A, Sato T, et al. Gene expression profile in human leukocytes. Blood. 2003;101:3509-13.
24. Labudova O, Kitzmueller E, Rink H, Cairns N, Lubec G. Increased phosphoglycerate kinase in the brains of patients with Down's syndrome but not with Alzheimer's disease. Clin Sci (Lond). 1999;96:279-85.
25. Abaza A, Soleilhac JM, Westendorf J, Piel M, Crevel I, Roux A, et al. M phase phosphoprotein 1 is a human plus-end-directed kinesin-related protein required for cytokinesis. J Biol Chem. 2003;278:27844-52.
26. Chen CH, Howng SL, Cheng TS, Chou MH, Huang CY, Hong YR. Molecular characterization of human ninein protein: two distinct subdomains required for centrosomal targeting and regulating signals in cell cycle. Biochem Biophys Res Commun. 2003;308:975-83.
27. Wolffe AP. Transcriptional activation. Switched-on chromatin. Curr Biol. 1994;4:525-8.
28. Katz S, Kowenz-Leutz E, Muller C, Meese K, Ness SA, Leutz A. The NF-M transcription factor is related to C/EBP beta and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells. EMBO J. 1993;12:1321-32.
29. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 1999;13:382-7.
30. Grumont RJ, Rourke IJ, Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 1999;13:400-11.
31. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991;1072:129-57.
32. Vogt PK, Bos TJ. jun: oncogene and transcription factor. Adv Cancer Res. 1990;55:1-35.
33. Hsu JC, Cressman DE, Taub R. Promoter-specific transactivation and inhibition mediated by JunB. Cancer Res. 1993;53:3789-94.
34. Sikora E, Radziszewska E, Kmiec T, Maslinska D. The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging. Acta Biochim Pol. 1993;40: 269-72.
35. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002;72:847-55.
36. Labudova O, Krapfenbauer K, Moenkemann H, Rink H, Kitzmuller E, Cairns N, et al. Decreased transcription factor junD in brains of patients with Down syndrome. Neurosci Lett. 1998;252:159-62.
37. Bruchova H, Kalinova M, Brdicka R. Array-based analysis of gene expression in childhood acute lymphoblastic leukemia. Leuk Res. 2004;28:1-7.
38. Yang MY, Liu TC, Chang JG, Lin PM, Lin SF. JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Blood. 2003;101:3205-11.
39. Salentin R, Gemsa D, Sprenger H, Kaufmann A. Chemokine receptor expression and chemotactic responsiveness of human monocytes after influenza A virus infection. J Leukoc Biol. 2003;74:252-9.
40. Wegner SA, Ehrenberg PK, Chang G, Dayhoff DE, Sleeker AL, Michael NL. Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1. J Biol Chem. 1998;273:4754-60.
41. Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, Littman DR, et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med. 2002;196:65-75.
42. Wool IG. Extraribosomal functions of ribosomal proteins. Trends Biochem Sci. 1996;21:164-5.
43. Borsatto B, Smith M. Reduction of the activity of ribosomal genes with age in Down's syndrome. Gerontology. 1996;42:147-54.
44. da Silva AM, Payao SL, Borsatto B, Bertolucci PH, Smith MA. Quantitative evaluation of the rRNA in Alzheimer's disease. Mech Ageing Dev. 2000;120:57-64.